MedPath

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

Completed
Conditions
Haemophilia B With Inhibitors
Haemophilia A With Inhibitors
Haemophilia B
Congenital Bleeding Disorder
Haemophilia A
Interventions
Other: No treatment given
Registration Number
NCT01988532
Lead Sponsor
Novo Nordisk A/S
Brief Summary

This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
381
Inclusion Criteria
  • Adult males able to provide consent and complete a survey in English
  • Congenital hemophilia A or B with or without inhibitors with any history of joint bleeding or joint pain
  • Presentation at the treatment center for a comprehensive annual visit where joint range of motion will be obtained
  • Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)
Read More
Exclusion Criteria
  • Previous participation in this study
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adult PWHNo treatment given-
Primary Outcome Measures
NameTimeMethod
Prevalence of acute (bleed-related) pain (percentage)At the first visit (only one study visit)
Prevalence of chronic (arthritic) pain (percentage)At the first visit (only one study visit)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Novo Nordisk Investigational Site

🇺🇸

Plainsboro, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath